The INDICAIDTM COVID-19 Rapid Antigen Test is a point-of-care
kit designed for the detection of SARS-CoV-2 antigens in direct nasal swab samples. The test is intended for use by healthcare professionals in symptomatic individuals within 5 days after onset of symptoms.

• CLIA Waived under FDA Emergency Use Authorization (EUA) 
• Results in 20 Minutes
• No equipment or training needed
• Simple sampling with self-collected shallow nasal samples
  easily collect and test multiple samples for batch testing

*This item is not eligible for return or refund

This product has not been FDA cleared or approved. The product has been authorized by the FDA under an EUA for use as a source control by the general public as well as by HCP in the healthcare setting to help prevent the spread of infection or illness during the COVID-19 pandemic. This product is authorized only for the duration of the declaration that circumstances exist to justify the authorization of emergency use of medical devices, including alternative products used as medical devices.